Tag Archives: ADC antibody-drug conjugates

Biotech Sell-Off Resumes: Caution Update 4/4

Update 4/4/14 Breach of Technicals-A Tad Below Early February Support Glut of Biotech IPOs Causing Indigestion? Momentum Days Are So Over NASDAQ Down 1.34% The volatile and speculative SPDR S&P Biotech XBI hit $136 in early trading down 2.28%.After a brief rally early this week to the $148 level volume picked up with sellers. The […]

Leave a comment Continue Reading →

Biotech Bull Market: OK Let’s Just Call It A Bubble

Biotech May Be A Bubble-But What to Do? The blogosphere is trying to temper bullish sentiment with a lot of “bubble “talk even though the cable channels are still pumping biotech.  If you have been around biotech for 25 years especially during the last true bubble -1999 -you should be a little skeptical of the […]

Comments Off Continue Reading →

Two Emerging Growth Biotechnology Stocks Hit $10B+ Valuations: INCY, PCYC

With Updates Today  2/13/14   XBI at $157.8 Biotechnology Bubblet- How High Can These Stocks Run? We reviewed mid-cap biopharmaceutical valuation in early October as part of our overall market model for a sector that defies classical analysis. Two emerging growth stocks in our model focused in oncology have soared to the $10B market cap […]

Comments Off Continue Reading →

Biotech Bull Market Up 6%+YTD: Key Trends to Watch Update #2

Biotech Bull Market Intact But Technicals Rule On January 27 we reiterated our model for life science stocks for 2014. We will review each component of our model and where the sector stands after about a 5% correction off highs with the sector still up 6% YTD depending on the index, fund or ETF (IBB). […]

Comments Off Continue Reading →

Rayno Biopharmaceutical Stocks Soar In January: ALXN, BIIB, PCYC Beat Indices

But Momentum Is Easing As Investors Cash Out-IBB Is 5.5% Off Jan 22 Highs Caution Rules With Selling Pressure-Raise Cash to 15% January 2014 was up 12% which  may be the best month ever in biotechnology at peak prices on January 22. But with the sector up over 62% over one year and 2013 being the […]

Comments Off Continue Reading →

Rayno Biopharmaceutical Update: CBST,IMGN,REGN,VPHM and Large Caps Rule

Biotech Remains Strong But Momentum Is Easing Biotechnology stocks were positive today but major ETFs mixed with the FBT ($63.82) off 1.45%.  Profit taking has hit some high fliers (AEGR,INCY) and many of our portfolio stocks are off their recent highs. Small and mid-caps are being sold off harder than larger caps with revenues and […]

Comments Off Continue Reading →